BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35064378)

  • 1. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
    Wang QM; Huang XY; Guan WQ
    Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
    Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
    Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircHLA-C: A significantly upregulated circRNA co-existing in oral leukoplakia and oral lichen planus.
    Yang J; Song Y; Xu S; Ge S; Haiwen Z
    Organogenesis; 2023 Dec; 19(1):2234504. PubMed ID: 37531467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overestimated risk of transformation in oral lichen planus.
    Cai X; Zhang J; Zhang H; Li T
    Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
    Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin-B and caveolin-1 gene expressions in oral lichen planus and oral squamous cell carcinoma.
    Pakfetrat A; Delavarian Z; Mohtasham N; Mohajer Tehran F; Samiee N
    Mol Biol Rep; 2022 Apr; 49(4):2945-2951. PubMed ID: 35138525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
    Jaafari-Ashkavandi Z; Aslani E
    Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between the quantity of oral mucosal micronucleus cells and cancerization].
    Cao J; Liu HW; Liu XS; Jin JQ; Zhang P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):600-2. PubMed ID: 21844976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
    Li TJ; Cui J
    Asian Pac J Trop Med; 2013 Aug; 6(8):640-3. PubMed ID: 23790336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus.
    Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of SIRT1, 6, and 7 in oral leukoplakia and oral squamous cell carcinoma.
    Sripodok P; Saito H; Kouketsu A; Takahashi T; Kumamoto H
    Odontology; 2024 Jan; 112(1):221-229. PubMed ID: 37191889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of survivin expression in leukoplakia, lichen planus, and oral squamous cell carcinoma: An immunohistochemical study.
    Angelin D; Nair BJ
    J Cancer Res Ther; 2020; 16(3):569-574. PubMed ID: 32719269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.
    Martín-Ezquerra G; Salgado R; Toll A; Baró T; Mojal S; Yébenes M; Garcia-Muret MP; Solé F; Quitllet FA; Espinet B; Pujol RM
    Histol Histopathol; 2011 Jan; 26(1):71-7. PubMed ID: 21117028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of p16(INK4A) protein in oral lichen planus.
    Montebugnoli L; Venturi M; Gissi DB; Leonardi E; Farnedi A; Foschini MP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):222-7. PubMed ID: 21612953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.